Search for: "Watson Laboratories Inc" Results 101 - 120 of 143
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Apr 2012, 9:05 am by FDABlog HPM
The owners of the three approved ANDAs for generic oral vancomycin—Akorn, Incorporated (“Akorn”), Watson Laboratories, Inc. [read post]
9 Nov 2007, 4:44 am
See, e.g., the Board's 2004 decision in favor of registrability of MOSCONI for billiard equipment (TTABlogged here), and this year's refusal of WATSON for laboratory software (here).Text Copyright John L. [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
1 Apr 2013, 8:29 am by Gene Quinn
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
11 Feb 2013, 6:44 pm by FDABlog HPM
District Court for the District of Columbia ruled against FDA in a challenge brought by Watson Laboratories, Inc. [read post]
23 Jan 2010, 9:40 am by Bill Marler
The Salmonella strain in the tested product does not appear to be the Montevideo strain of interest and further testing of the sample is ongoing at a state health partner laboratory. [read post]
23 Jan 2010, 9:46 am by Bill Marler
The Salmonella strain in the tested product does not appear to be the Montevideo strain of interest and further testing of the sample is ongoing at a state health partner laboratory. [read post]
23 Sep 2010, 12:39 pm by FDABlog HPM
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc.’s ANDA No. 78-278 for a generic version of the herpes drug FAMVIR (famciclovir) Tablets.  [read post]
16 Oct 2006, 7:58 pm
Solvay Pharmaceuticals settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. over Solvay's AndroGel drug product. [read post]
27 Sep 2010, 12:59 am by FDABlog HPM
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc.’s ANDA No. 78-278 for a generic version of the herpes drug FAMVIR (famciclovir) Tablets, FDA, on September 24th, updated the Agency’s drug approval database (Drugs@FDA) to show that ANDA No. 78-278 is tentatively approved.  [read post]
10 Jul 2013, 12:00 am
Watson Pharm., Inc. that routine experimentation is "not without bounds. [read post]